Royalty Pharma PLC (RPRX)
46.57
-0.45 -0.96%
NASDAQ
Feb 26, 20:00
USD
View All Key Stats
Key Stats
| Income Statement | |
| Revenue (TTM) | 2.122B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 1.242 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 975.04M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | 29.90% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield | 0.00% |
| Price and Valuation | |
| Market Cap | 28.27B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio | 8.100 |
| PE Ratio | 37.51 |
| Price to Book Value | 5.867 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio | 1.207 |
| Free Cash Flow (Quarterly) | 2.035B |
| Return on Equity | Upgrade |
View All RPRX News
News
-
WireHeadlineTime (ET)
-
Yahoo02/17 12:30
-
MT Newswires02/17 07:43
-
SA Breaking News02/17 07:10
-
MT Newswires02/17 07:03
-
Globe Newswire02/17 07:00
-
Yahoo02/17 05:45
-
SA Breaking News02/16 12:09
-
SA Breaking News02/16 11:42
-
Yahoo02/15 05:30
-
Yahoo01/29 23:35
-
Globe Newswire01/22 08:00
-
MT Newswires01/19 10:30
-
Globe Newswire01/19 08:30
-
SA Breaking News01/19 08:26
-
Globe Newswire01/19 08:00
-
MT Newswires01/08 08:33
-
Yahoo01/08 08:05
-
SA Breaking News01/08 08:03
-
Globe Newswire01/08 08:00
-
Globe Newswire01/07 16:15
View All Events
Events
| Date | Type | Description |
|---|---|---|
| 05/17/2021 | Earnings | Royalty Pharma PLC First Quarter Earnings Results for 2021 |
| 05/17/2021 08:00 EDT | Misc | Royalty Pharma PLC First Quarter Earnings Conference Call for 2021 |
| 02/18/2021 | Dividends | Amount: 0.17, Declared Date: Jan 08 2021, Pay Date: Mar 15 2021 |
| 02/17/2021 | Earnings | Royalty Pharma PLC Fourth Quarter Earnings Result for 2020 |
| 02/17/2021 08:00 EST | Misc | Royalty Pharma PLC Fourth Quarter Earnings Conference Call for 2020 |
| 11/19/2020 | Dividends | Amount: 0.15, Declared Date: Oct 15 2020, Pay Date: Dec 15 2020 |
| 11/11/2020 | Earnings | Royalty Pharma PLC Third Quarter Earnings Result for 2020 |
| 11/11/2020 08:00 EST | Misc | Royalty Pharma PLC Third Quarter Earnings Conference Call for 2020 |
| 09/14/2020 | Dividends | Amount: 0.15, Declared Date: Sep 02 2020, Pay Date: Sep 30 2020 |
| 08/12/2020 08:00 EDT | Misc | Royalty Pharma PLC Second Quarter Earnings Conference Call for 2020 |
Fundamentals
Income Statement View Statement
Ratings & Reports
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
- One Page Report Download
Advertisement
Edit
Profile
- URL: https://www.royaltypharma.com
- Investor Relations URL: N/A
- HQ State/Province: New York
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Mid Cap/Blend
- Next Earnings Release: May. 17, 2021
- Last Earnings Release: Feb. 17, 2021
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Feb. 18, 2021
- Description: Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company's portfolio consists of royalties on more than 45 marketed therapies and four development-stage product candidates. The therapies in portfolio address therapeutic areas such as rare diseases, oncology, neurology, HIV, cardiology and diabetes, and are delivered to patients across both primary and specialty care settings.
Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 46.57 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Top Fund Holders
| Symbol | Name | Weighting |
|---|---|---|
| MIGLX | Morgan Stanley Inst Global Advtg L | 4.53% |
| XPH | SPDR® S&P Pharmaceuticals ETF | 4.40% |
| JSMD | Janus Henderson Small/Md Cp Gr Alpha ETF | 2.88% |
| TCPWX | Transamerica Capital Growth R6 | 2.41% |
| MSKLX | Morgan Stanley Inst Discovery L | 2.36% |
| MAPLX | Morgan Stanley Inst Advantage L | 2.14% |
| FXH | First Trust Health Care AlphaDEX® ETF | 1.83% |
| FTQGX | Fidelity® Focused Stock | 1.65% |
| IBB | iShares Nasdaq Biotechnology ETF | 1.45% |
| IHE | iShares US Pharmaceuticals ETF | 1.44% |
| USGIX | USAA Growth & Income Class A | 1.37% |
| IPO | Renaissance IPO ETF | 1.18% |
Other Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- RPRX Tweets Stocktwits
Advertisement
